Towards 'Engagement 2.0': Insights from a study of dynamic consent with biobank participants

Grants

Funding Acknowledgements

Background work was partially supported by the Technology Strategy Board, the Engineering and Physical Sciences Research Council and the Economic and Social Research Council (grant number EP/G002541/1) for JK and EW. This represents independent research partly funded by the National Institute for Health Research (NIHR) sarcoma theme of the Musculoskeletal Biomedical Research Unit of the Oxford University NHS Trust based at the Botnar Research Institute at the Nuffield Orthopaedic Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.HT is funded under the Innovative Medicines Initiative joint Undertaking under grant agreement no. 115005, resources of which are composed of financial contribution from the European Union's seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution, and by Horizon 2020 (H2020/2014-2020) under project ID 643439. MM is funded through Innovative Medicines Initiative Joint Undertaking under Grant Agreement number 115439 (StemBANCC), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. JK is funded under Wellcome Trust Award 096599/2/11/Z and the EU F7 project BIOSHARE.